From cell and gene therapies to real world evidence and market access, the orphan drug value chain is the core focus at this European meeting. In Amsterdam, companies, regulators and patient organisations converge to discuss development pathways and access strategies.
Dates and venue for World Orphan Drug Congress - Europe 2026
The event runs from 26 to 28 October 2026 at the RAI Convention Centre in Amsterdam. 26 October is reserved for workshop sessions and 27 to 28 October cover conference programming and the exhibition.
Exhibitors and attendee profile in Amsterdam
The exhibition gathers biotech and pharmaceutical companies alongside service providers in clinical development, regulatory affairs and diagnostics. Delegates include market access teams, specialists in real world evidence, genetic testing providers and CDMOs active in cell and gene therapy.
Programme highlights and partnering
Content spans cell and gene therapy, genetic testing, market access and real world evidence. The format includes conference sessions, workshops and one to one partnering meetings that facilitate business development. There is also a startup zone and a biopharma showcase within the exhibition.
Key figures for the 2026 edition
Published metrics for the event indicate the scale of the meeting:
- 1,500+ attendees.
- 70+ exhibitors.
- 250+ speakers.
- 3 days of activity and more than 1,000 one to one partnering meetings.
These numbers reflect a dense programme for networking and targeted meetings across the rare disease ecosystem.
Preparing B2B outreach at the congress
Start with a targeted list of organisations and job functions you need to meet. For market access offerings, prioritise payer and market access leads. For technical services, identify CDMOs and diagnostics vendors on the exhibitor list. Use the event partnering platform to schedule 1 to 1 meetings in advance and keep initial outreach concise: state the business problem you solve and a measurable outcome.
Bring collateral that summarises clinical endpoints, regulatory status and any patient-centric data you can share. Reserve workshop slots to present technical capabilities and use follow up meetings immediately after the congress to capitalise on momentum.
Registration, sponsorship packages and the full agenda are available on the official site at http://www.terrapinn.com/conference/world-orphan-drug-congress. Arrive with prioritized targets and clear outcomes to convert meetings in Amsterdam into concrete partnerships.
